SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSI Technology ($GSIT) is trending due to news of a U.S. Army contract for its Gemini-II technology, sparking excitement around its potential in edge AI computing. The community is discussing the significance of this contract, comparing it to industry giants like NVIDIA, and speculating about future partnerships and buyouts. Some traders are also noting a potential short squeeze due to the stock's thin float.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as the company explores rare earth production at its U.S. mining sites, potentially shifting from a steel stock to a strategic metals powerhouse. The community is discussing whether this pivot, along with a recent MOU with a global steel producer, signals a company buyout or if CEO Lourenco Goncalves is misleading shareholders. Mixed Q3 results have some focused on cost cuts and renewed auto demand, while others question the company's debt and long-term strategy.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group Inc is trending due to significant price movement driven by the FDA accepting the resubmission of its Biologics License Application for RP1. The community is actively discussing the potential for new price targets and comparing REPL to other high-momentum tickers. Some traders express caution, noting the lengthy review process and potential for dilution, while others anticipate a continued upward trajectory.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending due to widespread outages reported across the platform, reportedly linked to issues with Amazon Web Services (AWS), sparking frustration and concerns among users who were unable to access their accounts and execute trades. The community is expressing distrust and contemplating switching to alternative brokerages, while also speculating about potential market manipulation during the outage. Despite the technical difficulties, the stock is experiencing high trading volume and price volatility, leading to discussions about its long-term potential.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF (BTC) is trending as Bitcoin tests new highs, with community discussions focused on resistance levels and potential pullbacks. There's debate around its role as a safe haven asset compared to gold, with some highlighting its historical performance during times of economic uncertainty. Additionally, the ETF's correlation with other crypto-related stocks and the broader market is being closely monitored.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors discuss the potential impact of recent preliminary Q3 results and raised FY guidance, with some expecting further gains. Community members are also focused on the company's strategic investment in TLPH and the upcoming Phase 3 data for TLPH's Niyad, while others express concerns about potential dilution and Joe Todisco's actions.

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.

Verastem Inc

Verastem is trending due to positive data readouts for their KRAS G12D inhibitor, particularly in lung cancer, sparking discussions about its potential as a leading candidate and buyout target; community chatter also highlights analyst upgrades and speculation around short squeezes, with some emphasizing the company's long-term potential amid market volatility. The ESMO 2025 data for GFH375 has generated excitement, with many pointing out the high ORR and DCR figures.

Knightscope, Inc. engages in the provision and development of security technology solutions. Its product portfolio includes the K1 stationary machine, the K3 indoor machine, the K5 outdoor machine, and the K7 multi-terrain four-wheel vehicle. Its machines patrol client sites without the need for remote control to provide a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area, and deter crime. The company was founded by William Santana Li and Stacy Dean Stephens on April 4, 2013 and is headquartered in Sunnyvale, CA.

Knightscope Inc - Ordinary Shares - Class A

Knightscope ($KSCP) is trending amidst community speculation around a potential pump and dump scheme and dilution concerns. Some investors are citing positive news such as new sales milestones and a partnership with Palantir, while others point to the company's history of reverse splits and offerings and question its long-term viability in the robotics sector against competitors like $AITX. The community is actively debating the influence of social media accounts and potential short squeezes.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity ($CELC) is surging after Phase 3 trial data showed significant improvement in survival for HR+/HER2- breast cancer patients, leading to analyst price target increases. The community is discussing potential insider manipulation and whether the stock was a pre-market pump and dump. Some believe institutions owning a large percentage of shares indicates further room to run, while others are comparing its trial results to competitors.

PIMCO Dynamic Income Fund is a non-diversified, closed-end management investment company. Its seeks current income as a primary objective and capital appreciation as a secondary objective. The company was founded on January 19, 2011 and is headquartered in New York, NY.

PIMCO Dynamic Income Fund

PDI is trending as investors discuss its high dividend yield and potential benefits from future rate cuts, although some express concerns about its sustainability. Community members are actively debating strategies like DRIP and comparing PDI to similar CEFs and BDCs. Additionally, there's chatter regarding the timing of dividend payments and potential special distributions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin

Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin Oramed Announces Transformative Joint Venture to Accelerate Development and...

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt PR Newswire NEW YORK, Oct. 7, 2024 NEW...

Oramed Letter to Shareholders

Oramed Letter to Shareholders Oramed Letter to Shareholders PR Newswire NEW YORK, June 26, 2024 Stock Repurchase Program Scilex Senior Secured NotePhase 3 Oral Insulin Trial in USJV with Chinese...

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock

Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common Stock PR Newswire NEW YORK, June 26, 2024 NEW YORK, June 26...

Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and Innovation

PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex ), an innovative revenue-generating company focused on acquiring, developing and commercializing...

Oramed Pharmaceuticals Full Year 2023 Earnings: Beats Expectations

Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...

Oramed Pharmaceuticals (ORMP, $3.24) Aroon Indicator entered an Uptrend on March 04, 2024.

Over the last three days, A.I.dvisor has detected that ORMP's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Oramed Pharmaceuticals (ORMP, $3.43) Aroon Indicator entered an Uptrend on March 01, 2024.

Oramed Pharmaceuticals (ORMP, $3.28) Aroon Indicator entered an Uptrend on February 29, 2024.

Oramed Pharmaceuticals (ORMP, $3.41) RSI Indicator left the overbought zone on February 28, 2024

This is a signal that ORMP's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It concentrates on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Oramed Pharmaceuticals, Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$2.27
Prev Close	$2.23
Open	$2.21
Dividend Yield	0.00%
50-Day Moving Average	$2.30
Beta	0.58
Avg. Volume	117,892.95
PE Ratio	-3.66

52-Week High	$3.09
52-Week Low	$1.82
Market Capitalization	$91.44M
EPS (Annual)	-$0.4668
Price to Book	0.59
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ORMP
Oramed Pharmaceuticals, Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORMP News

ORMPOramed Pharmaceuticals, Inc